Professor Baoying Huang

Professor Baoying Huang is a Professor of Infectious Diseases and Microbiology at the National Institute for Viral Disease Control and Prevention (IVDC), part of the China Center for Disease Control and Prevention (China CDC). She is currently the Associate Director of the Biotech Center for Viral Disease Emergency (BCVDE). Professor Huang’s work focuses on the development of vaccines and antiviral therapies for human coronaviruses (including SARS-CoV, MERS-CoV, and SARS-CoV-2), poxviruses (including monkeypox virus), and other emerging and re-emerging infectious diseases. 

In 2015, Professor Huang joined the Global Health Support Program organized by the Chinese government and worked at the Sierra Leone–China Friendship Biological Safety Laboratory. She contributed to establishing a laboratory network for Ebola monitoring, testing, and management in Sierra Leone. During the COVID-19 pandemic, she participated in the COVID-19 Emergency Projects for SARS-CoV-2 variant monitoring in China, focusing on the phenotypic characteristics of variants and their implications for vaccines, therapeutic medicines, diagnostic tools, and public health measures. 

With a background in virology and immunology, Professor Huang has also been engaged in the development of monkeypox vaccines and anti-orthopoxviral inhibitors since the 2022 monkeypox outbreak.